Sign In
Buy PGNY
$26.28
+0.200 (+0.767%)
At Close: Jun 22, 2026
Progyny: Long-Term Thesis Still Intact
04:30am, Saturday, 09'th Mar 2024
Progyny's stock is trailing the S&P 500 thus far in 2024 amongst macro concerns such as the Alabama court ruling on frozen embryos. However, Progyny's Q4 2023 revenue grew by 26%, and the company cont
Progyny, Inc. Announces Share Repurchase Program
07:30am, Thursday, 29'th Feb 2024
NEW YORK, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, announced today that its Board of Directors
Progyny Stock Is Falling After Earnings. What the IVF Ruling Means for It.
09:01am, Wednesday, 28'th Feb 2024
Shares of fertility-solutions firm Progyny are in the red on disappointing guidance. The company says the Alabama court ruling on in vitro fertilization won't affect it.
Progyny, Inc. (PGNY) Q4 2023 Earnings Call Transcript
10:20pm, Tuesday, 27'th Feb 2024
Progyny, Inc. (PGNY) Q4 2023 Earnings Call Transcript
Progyny, Inc. Announces Fourth Quarter 2023 Results
04:01pm, Tuesday, 27'th Feb 2024
Reports Record Full Year Revenue of $1,088.6 Million, Reflecting 38% GrowthAchieves 49% Growth in Adjusted EBITDA to Record $187.1 MillionIssues Financial Guidance for 2024, Crossing the $1.3 Billion
Alabama's Fertility Ruling Raises Challenges for Stocks of Fertility Benefits Providers
02:14pm, Friday, 23'rd Feb 2024
This week brought another blow for reproductive rights in the U.S. An Alabama Supreme Court handed down a ruling that not only can frozen embryos be classified as “children,” but destroying them c
3 Cash-Rich Stocks to Buy for Peace of MInd in 2024
01:36pm, Wednesday, 24'th Jan 2024
One of the fun things about writing about stocks for a living is the library of content you can draw upon for inspiration. Back in June 2020, we were deep in the pandemic, so I wrote a piece about cas
3 Mid-Cap Stocks Poised for a Breakout in 2024
06:10pm, Tuesday, 16'th Jan 2024
Important voices in the investment world predict that 2024 could be a very strong year for mid-cap stocks. Janus Henderson portfolio manager Brian Demain believes the outlook for mid caps looks favora
Progyny Inc.: Resilient Business Model With Strong Growth Ahead
09:20am, Saturday, 16'th Dec 2023
Progyny, Inc. demonstrates strong resilience and sustained growth potential in a weak macro backdrop. The company's revenue grew 37% year-over-year, beating estimates, with strong performance in ferti
Progyny (PGNY) is an Incredible Growth Stock: 3 Reasons Why
02:17pm, Monday, 13'th Nov 2023
Progyny (PGNY) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Progyny, Inc. to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
12:00pm, Friday, 10'th Nov 2023
NEW YORK, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced that P
New Strong Buy Stocks for October 30th
09:01am, Monday, 30'th Oct 2023
CVEO, FBP, EIG, MNTX and PGNY have been added to the Zacks Rank #1 (Strong Buy) List on October 30, 2023.
New Strong Buy Stocks for October 17th
08:16am, Tuesday, 17'th Oct 2023
MNTX, PGNY, GFF, RKDA and CYCC have been added to the Zacks Rank #1 (Strong Buy) List on October 17, 2023.
Progyny: 4 Reasons I Bought This Stock
05:00pm, Sunday, 15'th Oct 2023
There are several clear reasons to consider Progyny stock. The company's worth is overlooked, making it a sneaky value play for investors. Here's how Progyny's unique position in the industry and fina
4 Undervalued Medical Stocks to Buy Amid High Market Volatility
09:46am, Friday, 29'th Sep 2023
Amid volatility, undervalued companies with solid prospects cushion investors from market jitters, while their robust fundamentals ensure higher returns. ACHC, PGNY, EGRX and NRBO are four such stocks
